Search Preview
Delivering Quality Solutions In Early Phase Clinical Research - ACS
clinicalstudies.co.nzRegister Interest 0800 STUDIES
.co.nz > clinicalstudies.co.nz
SEO audit: Content analysis
Language | Error! No language localisation is found. | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Title | Delivering Quality Solutions In Early Phase Clinical Research - ACS | ||||||||||||||||||||||||||||||||||||
Text / HTML ratio | 37 % | ||||||||||||||||||||||||||||||||||||
Frame | Excellent! The website does not use iFrame solutions. | ||||||||||||||||||||||||||||||||||||
Flash | Excellent! The website does not have any flash contents. | ||||||||||||||||||||||||||||||||||||
Keywords cloud | Read Auckland ACS Clinical clinical Services studies Phase study Zealand Studies Trials Contact research Register Learn Participant Facilities subjects Medicine | ||||||||||||||||||||||||||||||||||||
Keywords consistency |
|
||||||||||||||||||||||||||||||||||||
Headings |
|
||||||||||||||||||||||||||||||||||||
Images | We found 18 images on this web page. |
SEO Keywords (Single)
Keyword | Occurrence | Density |
---|---|---|
Read | 20 | 1.00 % |
Auckland | 18 | 0.90 % |
ACS | 17 | 0.85 % |
Clinical | 10 | 0.50 % |
clinical | 8 | 0.40 % |
Services | 7 | 0.35 % |
studies | 7 | 0.35 % |
Phase | 7 | 0.35 % |
study | 6 | 0.30 % |
Zealand | 6 | 0.30 % |
Studies | 6 | 0.30 % |
Trials | 5 | 0.25 % |
Contact | 5 | 0.25 % |
research | 5 | 0.25 % |
Register | 4 | 0.20 % |
Learn | 4 | 0.20 % |
Participant | 4 | 0.20 % |
Facilities | 4 | 0.20 % |
subjects | 3 | 0.15 % |
Medicine | 3 | 0.15 % |
SEO Keywords (Two Word)
Keyword | Occurrence | Density |
---|---|---|
Read More | 17 | 0.85 % |
More Read | 9 | 0.45 % |
New Zealand | 6 | 0.30 % |
Clinical Studies | 6 | 0.30 % |
Auckland Clinical | 5 | 0.25 % |
Contact Us | 5 | 0.25 % |
of the | 5 | 0.25 % |
of a | 4 | 0.20 % |
About Us | 4 | 0.20 % |
Learn More | 4 | 0.20 % |
Phase I | 4 | 0.20 % |
Register Now | 3 | 0.15 % |
in the | 3 | 0.15 % |
I and | 3 | 0.15 % |
and the | 3 | 0.15 % |
as a | 3 | 0.15 % |
and II | 3 | 0.15 % |
II studies | 3 | 0.15 % |
Auckland New | 3 | 0.15 % |
to conduct | 3 | 0.15 % |
SEO Keywords (Three Word)
Keyword | Occurrence | Density | Possible Spam |
---|---|---|---|
Read More Read | 9 | 0.45 % | No |
More Read More | 6 | 0.30 % | No |
Auckland Clinical Studies | 5 | 0.25 % | No |
and II studies | 3 | 0.15 % | No |
Phase I and | 3 | 0.15 % | No |
Clinical Studies ACS | 3 | 0.15 % | No |
I and II | 3 | 0.15 % | No |
More Read more | 3 | 0.15 % | No |
University of Auckland | 2 | 0.10 % | No |
Studies ACS provides | 2 | 0.10 % | No |
ACS provides stateoftheart | 2 | 0.10 % | No |
Working with an | 2 | 0.10 % | No |
stateoftheart world class | 2 | 0.10 % | No |
world class research | 2 | 0.10 % | No |
class research facilities | 2 | 0.10 % | No |
research facilities and | 2 | 0.10 % | No |
facilities and the | 2 | 0.10 % | No |
and the expertise | 2 | 0.10 % | No |
the expertise to | 2 | 0.10 % | No |
expertise to perform | 2 | 0.10 % | No |
SEO Keywords (Four Word)
Keyword | Occurrence | Density | Possible Spam |
---|---|---|---|
Read More Read More | 6 | 0.30 % | No |
Read More Read more | 3 | 0.15 % | No |
Phase I and II | 3 | 0.15 % | No |
I and II studies | 3 | 0.15 % | No |
Auckland Clinical Studies ACS | 3 | 0.15 % | No |
to conduct your next | 2 | 0.10 % | No |
expertise to perform Phase | 2 | 0.10 % | No |
Clinical Studies ACS provides | 2 | 0.10 % | No |
Studies ACS provides stateoftheart | 2 | 0.10 % | No |
ACS provides stateoftheart world | 2 | 0.10 % | No |
provides stateoftheart world class | 2 | 0.10 % | No |
stateoftheart world class research | 2 | 0.10 % | No |
world class research facilities | 2 | 0.10 % | No |
class research facilities and | 2 | 0.10 % | No |
research facilities and the | 2 | 0.10 % | No |
facilities and the expertise | 2 | 0.10 % | No |
and the expertise to | 2 | 0.10 % | No |
the expertise to perform | 2 | 0.10 % | No |
to perform Phase I | 2 | 0.10 % | No |
conduct your next clinical | 2 | 0.10 % | No |
Internal links in - clinicalstudies.co.nz
Contact Us - Auckland Clinical Studies Website
Services - Auckland Clinical Studies Website
Clinical Services - Auckland Clinical Studies Website
Pharmacist Services - Auckland Clinical Studies Website
Biomarker Services - Auckland Clinical Studies Website
Regulatory Services - Auckland Clinical Studies Website
Quality Services - Auckland Clinical Studies Website
Facilities - Auckland Clinical Studies Website
Participant Portal - Auckland Clinical Studies Website
Participant FAQ - Auckland Clinical Studies Website
Current Trials - Auckland Clinical Studies Website
Completed Trials - Auckland Clinical Studies Website
Glossary - Auckland Clinical Studies Website
About Us - Auckland Clinical Studies Website
Why ACS? - Auckland Clinical Studies Website
Our People - Auckland Clinical Studies Website
News & Events - Auckland Clinical Studies Website
Our Published Research - Auckland Clinical Studies Website
Contact Us - Auckland Clinical Studies Website
About Us - Auckland Clinical Studies Website
Sitemap - Auckland Clinical Studies Website
Privacy Policy - Auckland Clinical Studies Website
Clinicalstudies.co.nz Spined HTML
Delivering Quality Solutions In Early Phase Clinical Research - ACS Register Interest 0800 STUDIES Contact Us Facebook Home Services Clinical Services Pharmacist Services Biomarker Services Regulatory Services Quality Services Facilities Participant Portal Participant FAQ Current Trials Completed Trials Register Now Glossary About Us Why ACS? Our People News & Events Our Published Research Select Page Delivering Quality, Timely Solutions In Early Phase Clinical Research Auckland Clinical Studies (ACS) provides state-of-the-art world matriculation research facilities and the expertise to perform Phase I and II studies for the pharmaceutical and biotechnology industry. About ACS Healthy Volunteers Needed Register Now Register Now Need somewhere to self-mastery your next clinical trial? Contact Us Contact Us Professor Ed Gane MB ChB, MD, FRACP, MNZM Professor Gane has a vast research experience. He is first tragedian of increasingly than 50-refereed publications. He has been Principal Investigator for many important and ground-breaking hepatitis studies conducted at ACS. LearnIncreasinglyAbout Us Want to get involved as a volunteer? Participant Info About Clinical Trials LearnIncreasinglyLearnIncreasinglyOur Facilities See our modern new facilities SeeIncreasinglySeeIncreasinglyCurrent Clinical Trials View our list of current studies and clinical trials LearnIncreasinglySearch Here Need somewhere to self-mastery your next clinical trial? Located In Auckland, New Zealand Professional & Friendly staff Modern FirstMatriculationFacilities State of the Art Research Award Winning Quality Assurance Completed Trials ViewIncreasinglyVenus ACS first became involved in developing a novel oral recipe for the treatment of hepatitis C under the Sponsorship of US biotech, Pharmasset, a visitor subsequently uninventive by Gilead Sciences Inc. Since that date, ACS has been integrally involved in the Phase 2 minutiae of the recipe (now known as sofosbuvir) under the study name Electron. Ground-breaking results of this study were recently published in the New England Journal of Medicine (N Engl J Med 2013;368:34-44). ReadIncreasinglyShrek ACS was asked to self-mastery a Phase I Absorption, Distribution, Metabolism & Excretion (ADME) study of a C14-labelled oncology agent. Working with an oncologist from University of Auckland and the Department of Nuclear Medicine at AucklandMunicipalityHospital, ACS dosed 8 subjects with a single infusion of the IMP. The subjects were inpatient for approximately 8 days until >85% of radiation was recovered. Continuous urine and fecal collections were made for liquid scintillation counting and thoroughbred samples placid for PK analysis. ReadIncreasinglyRead increasingly Cobra This Phase 1 study evaluated the pharmacokinetics and safety of a biosimilar in healthy volunteers. The rencontre was to recruit, randomise and dose 200 subjects in a 3-month timeframe. In collaboration with sister-company CCST, regulatory and Ethics Committee clearance was gained in two weeks for both sites under one application. Screening to last subject dosed was achieved in the 3-month timeframe. ReadIncreasinglyRead increasingly Lace This entry-in-human study evaluated the safety and efficacy of single ascending doses of a topical IMP as a wound healing wage-earner in 43 healthy volunteers. Working with an infectious diseases physician and a dermatologist, a series of dial biopsies were made and IMP dosed. The wounds were assessed histologically, photographically and visually at follow-up visits. This was a challenging study and successfully completed within well-set timelines. ReadIncreasinglyRead increasingly Why Auckland New Zealand? Auckland is New Zealand’s largest municipality and has a patient/volunteer regional catchment population of virtually 2 million. ACS is situated directly opposite Auckland’s leading tertiary referral hospital, AucklandMunicipalityHospital (ACH) and has wangle to a full range of medical specialities and LabPLUS, ACH’s premier medical laboratory. Auckland is fortunate in having many clinical research groups in most therapeutic disciplines associated with the Auckland School of Medicine and Auckland’s major tertiary hospitals. These researchers are fully supportive and keen to participate in joint ventures and recruit patients for Phase I and II studies. ACS is within walking loftiness of New Zealand’s major university, the University of Auckland; many of the students are willing to participate in healthy volunteer studies. ACS now has increasingly than 4,000 names on its volunteer data-base. The favourable New Zealand economic environment and supportive Regulatory system enables us to offer timely and quality services at a competitive price. News & Events ViewIncreasinglyACS stand out among IQVIA preferred clinical trial sites Auckland Clinical Studies has been recognized for superior performance and quality in clinical research in 2017. After stuff selected by IQVIA In November 2016 as their first preferred partner clinical trial site globally, ReadIncreasinglyReadIncreasinglyPROFESSOR ED GANE, THE 2017 NEW ZEALAND INNOVATOR OF THE YEAR Professor Ed Gane’s outstanding contributions to the minutiae of a simple and potent cure for chronic Hepatitis C were recently recognized when he was named the 2017 New Zealand Innovator of the year ReadIncreasinglyReadIncreasinglyAUCKLAND CLINICAL STUDIES AND QUINTILESIMS SIGN ACS joins Christchurch Clinical Studies Trust as the first two ECD QuintilesIMS Prime Sites ReadIncreasinglyReadIncreasinglySYMPOSIUM TO CELEBRATE 10YRS OF ACS The symposium on 12th October 2017 at the Marion Davis Libraray at ACH was to gloat the last 10yrs ReadIncreasinglyReadIncreasinglyUniversity of Hong Kong-Shenzhen Hospital delegation visiting ACS “ACS has an enviable global reputation not only based on their contribution to finding very constructive new treatments for chronic hepatitis C, but moreover as a result of innovative studies in many other therapeutic indications including oncology rare diseases” – Associate Prof Wai-Kay Seto ReadIncreasinglyReadIncreasinglyACS TURNS 10! 28 April 2017 – Auckland Clinical Studies (ACS) proudly prestigious 10 years as an early phase clinical pharmacology unit in Auckland, New Zealand. ReadIncreasinglyReadIncreasinglyAuckland Clinical Studies 3 Ferncroft Street, Grafton, Auckland 1010 About Us Auckland Clinical Studies (ACS) provides state-of-the-art world matriculation research facilities and the expertise to perform Phase I and II studies for the pharmaceutical and biotechnology industry. ReadIncreasinglyNavigateServices Facilities Participant Portal About Us Contact Us +64 9 3733474 Fax: +64 9 373 3479 Enquire Online PHYSICAL ADDRESS 3 Ferncroft Street Grafton Auckland 1010 New Zealand POSTAL ADDRESS PO Box 8963 Symonds St Auckland 1150 New Zealand Home Back To Top Sitemap Privacy Policy Contact Us Like Us On Facebook